1. Home
  2. KEQU vs CHRS Comparison

KEQU vs CHRS Comparison

Compare KEQU & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$35.26

Market Cap

106.3M

Sector

Industrials

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$1.31

Market Cap

177.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEQU
CHRS
Founded
1906
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.3M
177.7M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
KEQU
CHRS
Price
$35.26
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.51
AVG Volume (30 Days)
2.1K
1.0M
Earning Date
03-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
472.00
EPS
0.58
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
$73.08
Revenue Next Year
N/A
$30.94
P/E Ratio
$60.79
N/A
Revenue Growth
7.72
N/A
52 Week Low
$32.00
$1.09
52 Week High
$46.70
$2.62

Technical Indicators

Market Signals
Indicator
KEQU
CHRS
Relative Strength Index (RSI) 41.73 47.16
Support Level $35.14 $1.31
Resistance Level $35.35 $1.51
Average True Range (ATR) 1.10 0.07
MACD -0.26 -0.00
Stochastic Oscillator 46.57 16.67

Price Performance

Historical Comparison
KEQU
CHRS

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: